Category Archives: Healthcare Professionals

Florida Center for Cosmetic Laser Gynecology Supports Safewalk for Women

Florida cosmetic gynecologist Dr. Mark Scheinberg, a member of the Ultimate Makeovers Team, will participate in the Safewalk Run 5K on October 30th. The 12th annual Safewalk benefits Women in Distress, a non-profit group that provides safe shelter and critical services to families affected by domestic violence.

The event is timed and awards are given to top finishers as well as incentives for top fundraisers. All walkers and runners are asked to raise $200; the walk’s goal is to raise $100,000. The event will be attended by the Miami Dolphin Cheerleaders and organizers expect more than 1,200 people to participate.

Dr. Scheinberg is running in the race and he has also helped to sponsor the event. “At the Ultimate Makeover Team we want to use our resources to help less fortunate individuals and the community as a whole,” said Dr. Scheinberg, a Florida cosmetic gynecology provider.”Sponsoring the Safewalk helps to fulfill both goals.”

Dr. Scheinberg is part of the Ultimate Makeover Program, in which Florida’s best doctors and health practitioners go beyond changing people’s looks to transforming their lives. The Ultimate Team will help the less fortunate through community activism and fundraising corporate partnerships as well as through cosmetic procedures.

Each year the Ultimate Makeover Team will perform a makeover for a deserving member or members of the community at no cost to the participant. The makeover may include cosmetic dentistry, plastic surgery, laser eye surgery, and personal training. Makeover recipients will be chosen from local charities and the community. The Ultimate Team also helps through community activism and corporate partnerships to raise money for charity. This year’s charity is Women in Distress.

Learn More
To learn more about the Center for Cosmetic Laser Gynecology and Dr. Mark Scheinberg, visit their Web site at http://www.cosmeticlasergyn.com/ or phone at 888-573-7496.

Via EPR Network
More Healthcare press releases

South Florida Cosmetic Dentist Notes How Oral Health Affects the Whole Body

People tend to think of beautiful straight teeth as a purely cosmetic concern – a luxury rather than a necessity. However, teeth that are crooked, stained, or have other problems can cause physiological problems in the rest of the body or can be an indicator of other health problems.

“Crooked and crowded teeth are hard to clean properly, potentially leading to tooth decay, gum disease, and tooth loss,” notes Dr. Charles Nottingham, a Miami dentist and Fort Lauderdale dentist.”A bad bite can also cause abnormal wear of tooth surfaces, poor speech, and excessive stress on the jaw bone and gum tissue.”

Poor bites can also influence chewing and swallowing and food selection – leading to nutritional problems. Pain in the jaw or teeth can lead to pain in the head, neck, shoulders, or elsewhere in the body. Oral pain often leads to diminished activity, lost work days, depression, sleep problems, and missed school for children.

“In addition, problems with your teeth can be an indicator of whole-body health issues,” points out Dr. Nottingham, a South Florida cosmetic dentist.”Scientific research indicates a link between gum disease and many other overall health problems including: high blood pressure, heart disease, stroke, arthritis, premature births and many more.”

Sometimes teeth can reveal a previously unknown health condition. Conditions that can be detected in the mouth include diabetes (causesgum infections), acid reflux (teeth are much more prone to decay), some auto-immune disorders (the soft tissue in the mouth and salivary glands can be affected), liver diseases (the soft tissue in the mouth is jaundiced) and many more.

Via EPR Network
More Healthcare press releases

Global Health Progress Fact Sheet Projects China Will Become One of World’s Major Biopharmaceutical Players

Data revealed in Global Health Progress’ (GHP) new fact sheet shows that China is projected to become one of the world’s major biopharmaceutical players, along with the U.S., Europe, and Japan, in the next fifteen years. This projection is based on China’s commitment to improving access to healthcare by expanding its biotechnology sector, increasing its exportation of biopharmaceuticals and investing in pharmaceutical research and development (R&D).

China has one of the fastest growing economies in the world with a gross domestic product of more than $8 trillion. Its biotechnology sector has become a bright spot in the Asia Pacific region and the world markets, with an impressive average annual growth rate of 19.4% between 2000 and 2005, and is anticipated to become the world’s third-largest pharmaceutical market in 2011, a major increase over its #8 rank in 2000

Part of China’s successful growth is due to its decision to improve access to healthcare by increasing exports of biopharmaceuticals. For example, in 2006 China exported a total of US $890 million in biopharmaceuticals – a 30.61% increase compared with the previous year. China has also become the largest vaccine manufacturing country in the world, capable of producing 41 vaccines to prevent 26 viral diseases, and has become the third country to succeed in large-scale production of genetically engineered insulin.

Additionally, China’s pharmaceutical R&D expenditures are expected to reach US $10 billion or 2% of global spending by the end of 2010. The country is expected to contribute an additional $40+ billion in annual sales by 2013, comparable to the level of increased sales forecast for the US market in the same period.

China’s investment in the biotechnology sector has translated into improvements regarding access to healthcare and the country’s economic growth through creating high-quality, highly skilled jobs. Currently, there are more than 500 biotechnology companies in China with the biopharmaceutical sector employing approximately 50,000 people. Additionally, pharmaceutical R&D is taking the form of multinational biopharmaceutical companies setting up research facilities in biotechnology parks in China, which can drive highly-skilled, high wage job growth and encourage better access to healthcare.

Please view full PDF for additional information and list of sources.

Via EPR Network
More Healthcare press releases

Russia Reveals Renewed Commitment to Expand, Promote Biotechnology Sector

Global Health Progress (GHP) released a new fact sheet highlighting Russia’s commitment to expanding and promoting its biotechnology sector. Although the biopharmaceutical sector in Russia is less developed than other markets, the sector is making progress by implementing public policies that support pharmaceutical research and development (R&D) for life-changing treatments, contribute high-quality, high wage jobs to the region and increase the number of clinical trials offered to the population to improve access to drugs and help reduce the overall burden of disease.

Currently, Russia accounts for approximately 0.5% of the world biotechnology market, two-thirds of which are biopharmaceuticals. In 2010, the value of the biopharmaceutical market in Russia was estimated to be approximately US $17.2 billion, compared with US $10.4 billion in 2006. According to analysts, the Russian market is predicted to expand at a compound annual growth rate of 8.3% over the next few years and approximately 53% of the biopharmaceuticals market in Russia is comprised of innovative medicines.

As part of a national 10-year plan to promote biotechnology, the government is enacting policies to strengthen Russia’s pharmaceutical research and development (R&D) areas that have been historically strong. For example, special economic zones will focus on attracting investors to commercialize biotechnology and related innovations. Additionally, the Russian government is investing in “bioparks,” R&D clusters of biotechnology and related sectors.

Russia is well-known for its highly skilled scientific workforce and the biopharmaceutical sector has emerged as an important source of high-quality, highly skilled jobs. As the presence of biopharmaceutical companies increases, so does the pool of highly skilled doctors, scientists and researchers. According to Burrill & Company, the biopharmaceutical sector currently employs approximately 12,000 people with the average salary for a PhD scientist in Russia approximately US $1,800.

Currently, Russia ranks 12 out of 25 in terms of active clinical trials with 1,084 sites with an average relative annual growth rate of 33%. However, as of February 2010, there were 304 medicines in development in Russia, making the country one of the fastest annual growth rates. The growth in share of global clinical trials can bring health benefits, including the diffusion of medical knowledge and effective medical practice, greater patient access to high quality care and improve access to drugs. Clinical trials can also help reduce the overall burden of disease on the Russian population.

Via EPR Network
More Healthcare press releases

The Harley Medical Group Sees Steady Increase In Breast Reduction Procedures

The Harley Medical Group reports that it has seen a steady increase in breast reduction procedures in the UK. With breast surgery still top of the ops in the cosmetic surgery field, wanting to appear slimmer is an increasingly common motivator for women having breast reductions. A smaller looking frame helps towards the perception of an individual looking slimmer.

Lisa Littlehales, Specialist Nurse Councillor at The Harley Medical Group said: “We are seeing an increase in the current female generation opting for breast reductions. The average dress size for women these days is a 16 and many women have at least a size D bust. By decreasing chest size it helps women to look and feel thinner and also helps them in their quest to get fit and lose weight. Large breasts can cause back and neck troubles and also restricts women when trying to exercise – oversized and heavy breasts can be a huge inconvenience on women’s lives.”

Katherine Richards, breast reduction case study at The Harley Medical Group commented: “I suffered from terrible back and neck problems due to the sheer weight of my size H breasts. It was awful because a real passion of mine was running but I would have to wear two extra supportive sports bras and would often feel embarrassed when going to the gym. Since having surgery a weight has literally been lifted – I am now a manageable D-cup which makes running much more comfortable. I also have the confidence to wear a bikini on the beach which I could never ever do before.”

Breast reduction surgery usually takes three hours to complete, depending on the size of the breasts. The operation is carried out under general anaesthetic, and patients stay in hospital for one to two nights. Breast reduction patients are required to wear a supportive bra for up to three months following surgery to keep the breasts well supported whilst healing takes place and ensure the best possible results.

Via EPR Network
More Healthcare press releases

Brazil’s Biopharmaceutical Sector Contributes to Economic Growth, Expands Access to Healthcare

Global Health Progress (GHP) released a new report that reveals how the biopharmaceutical sector in Brazil, the tenth largest biopharmaceutical market in the world and the largest in Latin America, is an important driver for its economy. For instance, Brazil’s biopharmaceutical sector develops high-quality, highly skilled jobs, which is a key factor in creating a stable economy. Currently, approximately 821 biotechnology companies in Brazil employ almost 100,000 people with an average annual salary of approximately US $4,457. Among those companies, six biopharmaceutical companies were featured in a 2003 list of the top 100 companies to work for in Brazil.

Not only does the biopharmaceutical sector produce valuable job opportunities for highly skilled workers, this emerging market plays a critical role in fostering public-private partnerships, which leads to more economic growth and greater access to healthcare for its citizens.

Investment in research and development (R&D) and promoting innovation are key ways the Brazilian government is helping drive future growth of the country’s biopharmaceutical sector. For instance, R&D investments in Brazil have increased to 1.5% of GDP in 2010 and there are more than 205 highly trained physicians per 100,000 of the population serving as investigators for clinical studies.

“In Brazil, promoting innovation is a public policy priority,” stated Rafael Oliva, Advisor to the Presidency at the Brazilian Development Bank. “The participation of the Brazilian government in research and development (R&D) is considerable, and the goal is to both increase innovative activities in Brazil on a systematic basis, and to consolidate the country’s culture of innovation.” GHP fact sheet shows how Brazil’s investment in research and development (R&D) will create positive effects throughout the economy, including improving access to healthcare for its citizens through the production of new medicines. The growing field of clinical trials is also a significant factor in improving access to healthcare. Brazil’s large population of 190 million people, with 8 out of every 10 residents living in or near a city, means clinical trial recruitment and participation is fairly robust.

Via EPR Network
More Healthcare press releases

Non-corneal Tonometry Glaucoma Eye Test Independent of Central Corneal Thickness (CCT) and Biometric Properties Featured at ESCRS, Paris France

Unique non-corneal Tonometer Diaton, which allows to measure intraocular pressure (IOP) through the eyelid and sclera, unlike others that obtain IOP through cornea was featured at The European Society of Cataract and Refractive Surgeons ESCRS meeting in Paris, France.

Unique non-corneal Tonometer Diaton, which allows to measure intraocular pressure (IOP) through the eyelid and sclera, unlike others that obtain IOP through cornea was featured at The European Society of Cataract and Refractive Surgeons ESCRS.

Diaton tonometry is a unique approach of measuring intraocular pressure without touching the surface of the eye, takes tonometry reading over the upper eyelid and over the sclera. This revolutionary tonometry method allows physicians to obtain intraocular pressure without influence of central corneal thickness (CCT) and other known and unknown biometric properties and parameters of the cornea.

Unlike Goldmann tonometry which is based on the Imbert–Fick law and is effected by CCT and other corneal parameters and corneal diseases, where small area of the membrane is flattened to measure pressure of the internal fluid. Evidence shows that variations in CCT may greatly influence Goldmann tonometry reading. Parameters such as membrane elasticity, rigidity and other biomechanical properties can influence the accuracy of the intraocular pressure readings.

Diaton tonometry solves most of the corneal issues by implementing Newton ‘s Second Law and a Ballistic principle to obtain IOP. Readings with Diaton Tonometer are taken over the upper eyelid, at the tarsus and over the sclera, not the cornea.

Recent clinical study “Comparison of Accuracy of Diaton Transpalpebral Tonometer Versus Goldmann Applanation Tonometer, Dynamic Contour Tonometer and Ocular Response Analyzer “ concluded: “Transpalpebral Tonometry is an accurate method of IOP measurement that is also independent from the biomechanical characteristics of cornea. It can be recommended for IOP measurements of patients diagnosed with glaucoma including those cases where cornea pathology or cornea characteristics have been altered”.

BiCOM Inc. ( New York , USA ) covers the full scope of customer service, which involves client training, follow ups, hotline support, sales support, etc. To get more information on the device or to make a purchase, visit the official website –http://www.TonometerDiaton.com, or call BiCOM at the toll free number 1-877-diatons (877-342-8667).

Via EPR Network
More Healthcare press releases

Smile South Florida Cosmetic Dentist Selected for the Ultimate Makeover Team

In the spirit of ABC’s Extreme Makeovers and Fox’s the Swan, there is a new standard:The Ultimate Makeover. Those shows have made extreme aesthetic transformations popular nationwide, but the new program offers a twist. In the Ultimate Makeover Program, Florida’s best doctors and health practitioners go beyond changing people’s looks to transforming their lives. The Ultimate Team will help the less fortunate through community activism and fundraising corporate partnerships as well as through cosmetic procedures.

Nottingham Consulting Group sponsored a research investigation to discover South Florida’s top health practitioners. Each practitioner was selected by an independent panel using Ten Criteria. y qualifying and certifying the team, the community panel ensured that each practitioner meets a high standard of trust and professional ability.

The Ten Criteria are:

  • Years of experience
  • High quality education
  • Good standing in the community
  • Industry accolades and leadership
  • History of published works
  • Client testimonials
  • Tradition of community service
  • Praise from colleagues
  • A high degree of professionalism
  • Marketing

Each year the Ultimate Makeover Team will perform a makeover for a deserving member or members of the community at no cost to the participant. The makeover may include cosmetic dentistry, plastic surgery, laser eye surgery, and personal training. Makeover recipients will be chosen from local charities and the community.

The Ultimate Makeover Project raises money for a charity every year. The charity for 2010 is Women In Distress, the only nationally accredited, state-certified, full service domestic violence center serving Florida’s Broward County.

Charles Nottingham, D.D.S., F.A.G.D. was selected for The Ultimate Makeover Team because of his professional recognitions, quality of work, patient support, and community service. He has been hailed by da Vinci Studios, ABC’s Extreme Makeover Dental Lab, as “Florida’s Extreme Makeover Dentist.” Dr. Nottingham has received advanced training from the Pankey Institute and is a Fellow in the Academy of General Dentistry.

About Smile South Florida Cosmetic Dentistry

The cosmetic dentists at Smile South Florida Cosmetic Dentistry have offices in Broward County and West Palm Beach and provide Boca Raton Dentistry, FortLauderdale Dentistry and Miami Dentistry. They specialize in dental aesthetics including porcelain veneers, dental implants, extreme makeovers, Invisalign, and sedation dentistry.

Via EPR Network
More Healthcare press releases

Removing Intellectual Property Rights Will Only Worsen Africa’s Healthcare Crisis

In recent commentary in the Wall Street Journal, Alec van Gelder, Project Director at the International Policy Network wrote that strong intellectual property rights are critical to strengthening Africa’s health care system. He criticized statements by the Head of the World Health Organization Essential Medicines Program, Hans Hogerzeil. Hoberzeil wrote that “Big Pharma” and intellectual property rights are preventing the world’s poorest countries from receiving access to healthcare. Contradicting these assertions, van Gelder pointed out that the region’s lack of health infrastructure and the diversion of aid money are the real culprits behind the crisis.

“Drug companies do make easy targets but that doesn’t make them villains,” said van Gelder, “The life-saving treatments they create remain Africa’s best hope. The misguided battle against pharmaceutical companies’ patent rights will only make Africa’s health crisis worse.”

van Gelder notes that the growing field of public-private partnerships have resulted in a twelve-fold increase in patients receiving treatment over the last decade and have created a program of voluntary patent licenses for lower-cost “generics” manufacturers. Furthermore, fewer than 5% of WHO’s 423 Essential Medicines are currently protected by patents and these are mostly advanced “second-line” anti-AIDS medicines.

Global Health Progress (GHP) is actively supporting public-private partnerships to help address the need for access to medicines. Strong patent protection and intellectual property rights are critical components of these efforts to treat the public health challenges that the world’s poorest countries face. As van Gelder aptly points out, “Trampling over intellectual property rights removes drug companies’ incentives to invest billions of dollars in the development of the next generation” of much-needed and sought after drugs.

Rather, GHP supports the continued development of public-private partnerships, research and development and protection for intellectual property rights. These policies ensure that developing countries continue to have drugs available at reasonable costs, that pharmaceutical companies continue to embrace innovations and that all organizations can work together to improve healthcare infrastructure worldwide.

Via EPR Network
More Healthcare press releases

Canadian Pharmacy Intermediary Save Rx Canada Upgrades Online Shopping System

SaveRxCanada.com the premier Canadian pharmacy intermediary since 2004, announced an upgrade to its full online shopping system.

SaveRxCanada.com has been at the forefront of connecting consumers to affordableCanada drugs though its unique network of licensed Canada pharmacies and International online pharmacies.

SaveRxCanada.com has upgraded a number of features on its website (http://www.saverxcanada.com) to allow for better ease-of-use including an improved shopping cart, search tools, enhanced security with full digital encryption, and better customer service tools.

These improvements allow patients to securely order their medications online in a safe and easy way. Patients will also be able to create their own account without the need to print any documents, allowing orders to be processed and shipped faster.

The site also suggests how customers can adjust order size to maximize further savings. The improved shopping cart is also enhanced by exceptional customer service features. Customers can call toll-free or access a ‘live chat’ feature and have questions answered in real time by a ‘virtual’ customer service advisor.

Sizewise Launches First-of-its-Kind Automated Chair-to-Stretcher Device for Safe Patient Handling and Hospital Transport

Sizewise, a growing and diversified medical equipment manufacturer, today announced the newest in its Shuttle Series of products — the industry’s most advanced and secure means for mobilizing patients in a hospital setting. The Shuttle A Seriesâ„¢ is built on the strength and design of its predecessor The Shuttle B Series, which serves as a bariatric transport device.

“We’ve dominated the market with the Shuttle B Series, the only product of its kind to support up to 1,000 lbs, and now we’re pleased to deliver on the demand we’ve heard to create the same Shuttle for more average-sized patients,” said Trever Frickey, chief operating officer at Sizewise.

The Shuttle A Series is the ultimate transitional medical device designed for use in rehabilitation, examination and transportation. The Sizewise Shuttle Series of products are designed to help caregivers with safe patient handling so both the patient and healthcare professional do not suffer costly or life-threatening injuries.

“The Shuttle A Series transforms with the touch of a button from stretcher to chair position and is perfect for use with a lateral transfer device to assist with ambulating a patient,” said Frickey. “The seat assist function is complete with ambulation poles for the safety and confidence of the patient and caregiver.”

Uniquely, the Shuttle A Series has a tilt and recline function, along with an escalating height up or down. The seat has a three-layer foam insert for further comfort and weight distribution and leg supports elevate independently with retractable foot rests. The Shuttle A Series supports a weight capacity of 650 lbs and is the third in a line of Shuttle products – The Shuttle B Series™ and B Series LTC™ (a more economical model) are designed for the bariatric patient up to 1,000 lbs.

With an optional Power Drive, The Shuttle A Series can safely navigate smooth floors, thick carpet and uneven terrain in both the chair and stretcher position. With the ease of a feather-touch hand control, caregivers can propel patients at variable speeds up ramps and over door jambs. A unique center wheel design allows for easy maneuvering.

Via EPR Network
More Healthcare press releases

‘Drugging the Undruggable’ Symposium Highlights Advances in Treating Cancer, Diabetes and Other Major Diseases

Scientists from government, industry, and academia presenting at the 240th National Meeting of the American Chemical Society released a new report highlighting advances in creating the next generation of medicines for treating cancer, diabetes, and other major diseases. The report, which was featured during the special symposium, “Drugging the Undruggable,” summarized progress in drug development for diseases that were once considered “untouchable.” These treatments specifically targeted conditions where previous efforts to develop a drug therapyhad failed.

However, after decades of a seemingly impossible search, scientists appear to be making a breakthrough in the area of drug development to treat cancers and other diseases. As Science Daily noted in their coverage of the report and symposium, scientists have identified “stapled peptides,” a new family of potential drugs capable of blocking a key protein that’s involved in the development of cancer.

Global Health Progress (GHP) supports symposium presenters’ statements regarding the importance of these type of drug developments. For instance, Gregory Verdine, a chemical biologist at Harvard University, explained:

“The entire pharmaceutical industry has been working on drug-design platforms that focus on this little sliver of human drug targets and this limits the drug arsenal available to doctors. What’s required is an entirely new class of drugs that overcome the shortcomings of drugs of the past.” Innovative research and development (R&D) of new drugs is critical in improving overall healthcare, combating epidemics and fighting diseases. Drug development is just one way research-based biopharmaceutical companies serve as active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people both domestically and internationally.

Via EPR Network
More Healthcare press releases

The Harley Medical Group Report Surge In Liposuction Procedures

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed ‘beach envy’ – jealousy of other women’s bodies – hit holidaymakers.

The rise has been driven largely by 30-plus women, with clinic staff reporting patient feedback that suggests Victoria Beckham has the most coveted star stomach. Abdominoplasty surgery enquiries are also up 32% over the last two months with some patients even taking their summer holidays as ‘surgery breaks’, using the time off to recover before returning to work rejuvenated.

Liz Dale, Director of The Harley Medical Group said: “You can get liposuction on various areas of the body, not just the stomach area. It can be used to target problem areas such as the hips, buttocks, inner and outer thighs, knees and double chins.

“Many of our patients come back from a holiday with a resolution to make a change to their life. With pictures of celebrities soaking up the sun in bikinis hitting the newspapers every day, British women are being spurred into taking action.”

Liposuction is performed under a general anaesthetic and takes one to two hours. A very small incision is used to insert the cannula to extract the fat and sometimes this is closed with a stitch or dissolvable suture. Following the operation, patients are required to rest for 48 hours and avoid bending and heavy lifting. Patients must wear a support garment until advised otherwise by their consultant.

Via EPR Network
More Healthcare press releases

The Harley Medical Group Reports In Increase In Bald Patch Treatments

The Harley Medical Group has reported demand from male patients for laser rejuvenation treatments is up +93% over the last quarter, across its 30 clinics.

Laser rejuvenation treatments now account for 11% of all non-surgical treatments carried out during June, July and August at the UK’s largest cosmetic surgery group. More unusual requests received this year are for skin regeneration treatments on receding hairlines, including laser treatment and chemical peels to reduce the appearance of aging sun spots.

Laura Marshall, specialist nurse counsellor at The Harley Medical Group, said: “The skin on the scalp is delicate and when not protected by hair or high factor sun cream is prone to burning which can cause dark patches, spots and wrinkles to form. Coming to terms with a receding hairline has always been a challenge for a man, but to then suffer the effects of sun damage on the balding area adds insult to injury. Rejuvenation treatments can help minimise the visible signs of aging skin.”

Liz Dale, Director, The Harley Medical Group added: “We’re not talking big numbers of bald–patch treatments but the fact we’re getting more enquiries does demonstrate how men are taking non-surgical treatments increasingly seriously as a cosmetic solution. With successful, high profile men, like Simon Cowell, openly talking about their cosmetic regimes it’s a subject that has become more acceptable for men to tackle.”

Via EPR Network
More Healthcare press releases

Medicines for Malaria Venture (MMV) Joins The Pool for Open Innovation Against Neglected Tropical Diseases

Global Health Progress (GHP) is pleased to highlight the announcement that the not-for-profit public-private partnership Medicines for Malaria Venture (MMV) will became the first product development partnership (PDP) to contribute intellectual property to The Pool for Open Innovation against Neglected Tropical Diseases (The Pool).

MMV joined GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and the Massachusetts Institute of Technology (MIT) in providing intellectual property to The Pool. Discussing the decision, Professor Patrick Nef, Executive Vice President of Business Development at MMV, states, “In this way we hope to make fully available the know-how and technologies, assembled by MMV against malaria, for the research and development of innovative and efficacious treatments for other neglected diseases.”

By emphasizing a more accessible approach to intellectual property and know-how, The Pool facilitates access to patents and/or technologies for organizations that want to conduct research on treatments and motivates innovative and efficient drug discoveries and developments for neglected diseases.

The Pool is administered by BIO Ventures for Global Health (BVGH). It’s accessible to industry, non-profit institutions, and academic researchers who conduct research and drug development activities that deliver real benefits for patients in the least developed countries of the world.

Global Health Progress echoes the sentiment that MMV’s contribution of patents to The Pool, resulting from its research for new antimalarials, is an important milestone from an organization that plays a major role in leading the development of new therapeutics for malaria.

Global Health Progress supports the continuing partnership between not-for-profit public-private partnerships and research-based biopharmaceutical companies as a way to fight neglected tropical disease through targeted research and development (R&D), improving access to critical medicines and providing key intellectual property.

Via EPR Network
More Healthcare press releases

New You Boot Camp Launches New Corporate Events Division

New You Boot Camp, Europe’s leading weight loss & fitness boot camp has launched a new Corporate Events Division to further expand its portfolio of motivational, inspiring and rewarding services to companies across Europe.

New You Boot Camp is an established, highly acclaimed, award winning military style boot camp with experience of providing creative, residential and day events which focus on developing motivation within teams.

“Launching a corporate side has been a very natural progression for New You Boot Camp,” says Jacqui Cleaver, Director and Co-Founder of New You Boot Camp “Whilst we offer a range of services to meet the motivation, rewards and recognition needs of our clients, we are now very pleased to be able to design and deliver bespoke, national and international event experiences for our corporate customers.”

New You Boot Camp is the only company offering corporate customers an extensive range of bespoke and set military experiences that are perfect for any group. For clients with individual needs, events can be tailor made; whether the event is 1 hour, 1 day or one week.

New You Boot Camp’s corporate events can be arranged in locations up and down the country and incorporate fun and authentic military training experiences including; section attacks, military circuits, static training, leopard crawling and team based challenges to name a few.

On request New You Boot Camp can integrate further outdoor activities such as coasteering, gorge walking, mountain biking, canoeing, bell boating and caving ensuring each corporate event is tailoring to each clients needs.

Recent corporate client, Steve Lloyds from TSB Private Banking said “Everything from the location, itinerary, accommodation facilities etc were perfect. New You Boot Camp certainly put us through our paces, they did a great job in ensuring that everyone, despite the varying degrees of fitness could participate and really get involved. It was exactly what I wanted for a team day experience.”

Via EPR Network
More Healthcare press releases

Global Health Progress Stresses Importance of Product Development Partnerships

Helen Coster’s recent commentary in her new Forbes blog Good Work addresses the issue of how product development partnerships (PDPs) can develop and improve treatments for neglected diseases like malaria, leishmaniasis, and Chagas disease.

Coster notes, “These diseases affect the world’s poorest people, and they often get ignored by pharmaceutical companies for a simple economic reason: there is no way that considerable investment in research will be recouped in drug sales.”

Coster’s entry highlights the work of some of the best-known PDPs, such as the Drugs for Neglected Disease Initiative, Global Alliance for Vaccines and Immunization, the International AIDS Vaccine Initiative and the Global Fund to Fight AIDS, Tuberculosis & Malaria. Coster also highlighted the significant funding of PDPs by The Bill and Melinda Gates Foundation.

In closing, Coster invites her readers to discuss the PDP approach to eradicating neglected diseases and what role, if any, the pharmaceutical industry, philanthropists and other global organizations should play in the fight.

Global Health Progress also believes that public-private product development partnerships are invaluable in expanding the capacity of research and development (R&D) on innovative drugs and vaccines for neglected diseases. These partnerships help by harnessing the technical expertise and resources of the private sector with the approach of universities, research institutes and other public organizations.

Via EPR Network
More Healthcare press releases

Top Government Hospital for Stem Cell Treatments and Research Located in Beijing Launches English Website

The Stem Cell Transplantation Department at the General Hospital of Chinese People’s Armed Police Forces has launched an English version of its website www.sinostemcells.com for its ever-growing international patients seeking Stem cell treatments. The new user-friendly site reflects the department’s vision of readily available, authentic, and relevant information and aims to supply its online visitors with up-to-date information on the department’s current stem cell therapies and research programs.

The Stem Cell Transplantation Department Director Dr. Yihua An, PhD, says “Access to relevant, quality information is becoming more important for international patients, their physicians, and families. We have met the ever-increasing need for English language updates on our current research direction and practices and have developed a modern English website especially designed for a Western audience.”

The department is located at the General Hospital of Chinese People’s Armed Police Forces in Beijing – a top Level 3A military institution that integrates healthcare services, scientific research, and medical education.

The Stem cell department is active in the field of stem cell treatments and research. The department primary focus is on Stem cell treatment for Spinal Cord Injury and Brain Injury apart from central nervous system -related diseases like Cerebral palsy and Stroke.

Via EPR Network
More Healthcare press releases

The Harley Medical Group Reports Boom In Pre-Wedding Breast Enlargement

The Harley Medical Group has reported that, with the wedding season at its peak, there has also been a corresponding significant rise in breast augmentation surgery.

Determined to look perfect on their big day, brides are taking the plunge and booking in for a boob job for additional confidence on their big day. As a result, breast enlargement is top of the ops this summer across the Group’s 30 clinics in the UK and Ireland.

Liz Dale, Director, The Harley Medical Group, commented, “The big wedding is certainly in vogue in 2010, so pre-wedding procedures are right back on the agenda, with the lucky couples determined to have a picture perfect record of their special day.

“With the average wedding costing nearly £20,000, patients see cosmetic procedures as a long term investment, with the effects of plastic surgery lasting well beyond the big day itself. The average pre-nup nip budget is around £4,000 and is favoured by those plumping for long engagements – we recommend patients allow a good four to six months recovery time to ensure the best results on their wedding day.”

Lisa Littlehales, Nurse Counsellor and Clinic Manager at The Harley Medical Group commented, “The split of brides to grooms having pre-wedding surgery is around 75% to 25%. For women their figure is definitely the focus – it is all about the dress, after all. The men we see are frequently looking to correct a sporting injury, so things like having rhinoplasty on a broken nose.”

Via EPR Network
More Healthcare press releases

Recent African Leaders Malaria Alliance Meeting Highlights Importance of Partnerships to Ensure Continued Progress on Malaria Vaccine

During the recent African Union summit, the African Leaders Malaria Alliance (ALMA) gathered to discuss how to combat the threat of malaria in the continent. Inspired by this meeting, Madiké Seye, Vice-President for Africa – GlaxoSmithKline wrote a guest article on the Independent’s website calling for “new tools, such as a malaria vaccine, which could complement existing interventions.”

Seye wrote, “Vaccines and immunization services have been critical to improving Africa’s health over the last several decades. Anyone whose child has suffered f r o m malaria – and there are only few of us who have not directly been affected by the disease – can imagine what a malaria vaccine would mean.”

F r o m there, Seye highlighted the importance of partnerships between African leaders, policymakers, international groups and the pharmaceutical industry. These collaborations are required in order to move forward with making the dream of a malaria vaccine a reality, whether that’s through improving drug prices or investing in technology to fully develop the vaccine. Seye noted that the vaccine is already in the final phases of development and trial results have consistently shown an “acceptable safety profile.”

Global Health Progress supports the role of these public and private partnerships and the participation of the pharmaceutical industry, particularly when it comes to addressing issues involving drug prices, access to medicines, and the continued efforts to create innovative new drugs and vaccines. GHP believes research and development are especially critical components of improving health care and combating epidemics of neglected tropical diseases, such as malaria, in developing countries.

GHP echoes Seye’s call for countries, multilaterals, NGOs, the pharmaceutical industry and scientists to continue to work together to, “make sure Africa is ready for a vaccine. One day there may be the means to save many more lives and change the equation in the fight against malaria for good.”

Via EPR Network
More Healthcare press releases